The headline is that the UK–India Free Trade Agreement has stalled on a pharmaceutical intellectual property clause. The reality — and the reality that matters for positioning — is that the bilateral tech and services corridor has decoupled from the FTA process entirely. Trade in technology services, digital infrastructure, and professional services between the two markets is accelerating regardless of the political impasse.
The Decoupled Corridor
UK-India tech trade has grown 34% year-on-year without any formal trade agreement. The drivers are structural: Indian engineering talent deploying into UK firms through the skilled worker visa route, UK fintech platforms expanding into Indian financial markets, and a growing cross-border data services ecosystem that operates under existing WTO frameworks.
The pharma IP deadlock, while significant for the pharmaceutical sector, does not affect the technology and services flow. For investors and operators in the tech corridor, the FTA stall is noise. The signal is the structural growth of bilateral technology trade — and the opportunity it creates for firms positioned at the intersection.